Professional
Added to YB: 2024-05-29
Pitch date: 2024-03-31
BAYN.DE [neutral]
Bayer Aktiengesellschaft
+39.93%
current return
Author Info
No bio for this author
Company Info
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
Market Cap
EUR 36.9B
Pitch Price
EUR 28.37
Price Target
N/A
Dividend
0.29%
EV/EBITDA
7.31
P/E
-10.20
EV/Sales
1.47
Sector
Pharmaceuticals
Category
turnaround
Harris Associates Global Strategy Portfolio Holding: Bayer Aktiengesellschaft
BAYN.DE: Recent RoundUp jury verdict bigger than avg but likely reduced on appeal; since won 2 cases. Capital markets day lacked major updates as litigation strategy kept private, no mid-term targets, and break-up deferred for balance sheet. Support mgmt's profitability & cash focus + bureaucracy cuts. 2023 results & 2024 guide in line.
Read full article (1 min)